Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes

Molecular and Cellular Endocrinology

Volumn 239, Issue 1-2, 2005, Pages 55-61

  Chun, Tae Yon ^a   Pratt, J Howard ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aldosterone; Cardiomyocytes; Plasminogen activator inhibitor 1; Transforming growth factor 1

Indexed keywords

ALDOSTERONE; DACTINOMYCIN; DEXAMETHASONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; RECEPTOR BLOCKING AGENT; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; FIBROSIS; HEART MUSCLE CELL; HORMONAL REGULATION; HORMONE ACTION; HORMONE RESPONSE; MEDIATOR; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT; RNA ANALYSIS;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; MYOCYTES, CARDIAC; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 20544458728     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.03.016     Document Type: Article

References (33)

1. C.G. Brilla, P. Pick, L.B. Tan, J.S. Janicki, and K.T. Weber Remodeling of the rat right and left ventricles in experimental hypertension Circ. Res. 67 1990 1355 1364
2. N.J. Brown, M.A. Agirbasli, G.H. Williams, W.R. Litchfield, and D.E. Vaughan Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1 Hypertension 32 6 1998 965 971
3. N.J. Brown, K.S. Kim, Y.Q. Chen, L.S. Blevins, J.H. Nadeau, S.G. Meranze, and D.E. Vaughan Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production J. Clin. Endocrinol. Metab. 85 1 2000 336 344
4. N.J. Brown, S. Nakamura, L. Ma, I. Nakamura, E. Donnert, M. Freeman, D.E. Vaughan, and A.B. Fogo Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo Kidney Int. 58 3 2000 1219 1227
5. L.A. Calo, F. Zaghetto, E. Pagnin, P.A. Davis, P. De Mozzi, P. Sartorato, G. Martire, C. Fiore, and D. Armanini Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes J. Clin. Endocrinol. Metab. 89 4 2004 1973 1976
6. T.Y. Chun, L. Bloem, and J.H. Pratt Spironolactone increases integrin beta3 gene expression in kidney and heart muscle cells Mol. Cell Endocrinol. 194 1-2 2002 175 182
7. T.Y. Chun, L.J. Bloem, and J.H. Pratt Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes Endocrinology 144 5 2003 1712 1717
8. T.Y. Chun, D. Gregg, D.K. Sarkar, and J. Gorski Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth Proc. Natl. Acad. Sci. U.S.A. 95 5 1998 2325 2330
9. A.A. Eddy Plasminogen activator inhibitor-1 and the kidney Am. J. Physiol. Renal. Physiol. 283 2 2002 F209 F220
10. M. Eren, C.A. Painter, L.A. Gleaves, J.A. Schoenhard, J.B. Atkinson, N.J. Brown, and D.E. Vaughan Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice J. Thromb. Haemost. 1 11 2003 2389 2396
11. J.A. Hamilton, G.A. Whitty, J. Wojta, M. Gallichio, K. McGrath, and G. Ianches Regulation of plasminogen activator inhibitor-1 levels in human monocytes Cell Immunol. 152 1 1993 7 17
12. A. Hamsten, U. de Faire, G. Walldius, G. Dahlen, A. Szamosi, C. Landou, M. Blomback, and B. Wiman Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Lancet 2 8549 1987 3 9
13. A. Hamsten, B. Wiman, U. de Faire, and M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N. Engl. J. Med. 313 25 1985 1557 1563
14. W.E. Hopkins, D.R. Westerhausen Jr., B.E. Sobel, and J.J. Billadello Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor Nucleic Acids Res. 19 1 1991 163 168
15. K. Kaikita, A.B. Fogo, L. Ma, J.A. Schoenhard, N.J. Brown, and D.E. Vaughan Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition Circulation 104 7 2001 839 844
16. M.R. Keeton, S.A. Curriden, A.J. van Zonneveld, and D.J. Loskutoff Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta J. Biol. Chem. 266 34 1991 23048 23052
17. D.J. Loskutoff, and J.P. Quigley PAI-1, fibrosis, and the elusive provisional fibrin matrix J. Clin. Invest. 106 12 2000 1441 1443
18. L.R. Lund, A. Riccio, P.A. Andreasen, L.S. Nielsen, P. Kristensen, M. Laiho, O. Saksela, F. Blasi, and K. Dano Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts EMBO J. 6 5 1987 1281 1286
19. E.M. Oestreicher, D. Martinez-Vasquez, J.R. Stone, L. Jonasson, W. Roubsanthisuk, K. Mukasa, and G.K. Adler Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-l-arginine methyl ester-induced myocardial injury Circulation 108 20 2003 2517 2523
20. B. Olofsson, E. Korpelainen, M.S. Pepper, S.J. Mandriota, K. Aase, V. Kumar, Y. Gunji, M.M. Jeltsch, M. Shibuya, K. Alitalo, and U. Eriksson Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells Proc. Natl. Acad. Sci. U.S.A. 95 20 1998 11709 11714
21. M. Pahor, L.V. Franse, S.R. Deitcher, W.C. Cushman, K.C. Johnson, R.I. Shorr, K. Kottke-Marchant, R.P. Tracy, G.W. Somes, and W.B. Applegate Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1 Circulation 105 4 2002 457 461
22. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, and M. Gatlin Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N. Engl. J. Med. 348 14 2003 1309 1321
23. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure N. Engl. J. Med. 341 1999 709 717
24. W. Qin, A.E. Rudolph, B.R. Bond, R. Rocha, E.A. Blomme, J.J. Goellner, J.W. Funder, and E.G. McMahon Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure Circ. Res. 93 2003 69 76
25. P.M. Ridker, C.L. Gaboury, P.R. Conlin, E.W. Seely, G.H. Williams, and D.E. Vaughan Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function Circulation 87 6 1993 1969 1973
26. R. Rocha, P.N. Chander, K. Khanna, A. Zuckerman, and C.T. Stier Jr. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats Hypertension 31 1 Pt 2 1998 451 458
27. R. Rocha, C.T. Stier Jr., I. Kifor, M.R. Ochoa-Maya, H.G. Rennke, G.H. Williams, and G.K. Adler Aldosterone: a mediator of myocardial necrosis and renal arteriopathy Endocrinology 141 10 2000 3871 3878 (in process citation)
28. O. Saksela, D. Moscatelli, and D.B. Rifkin The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells J. Cell Biol. 105 2 1987 957 963
29. O. Saksela, and D.B. Rifkin Cell-associated plasminogen activation: regulation and physiological functions Annu. Rev. Cell Biol. 4 1988 93 126
30. P. Sawathiparnich, S. Kumar, D.E. Vaughan, and N.J. Brown Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans J. Clin. Endocrinol. Metab. 87 2 2002 448 452
31. J. Schneiderman, M.S. Sawdey, M.R. Keeton, G.M. Bordin, E.F. Bernstein, R.B. Dilley, and D.J. Loskutoff Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries Proc. Natl. Acad. Sci. U.S.A. 89 15 1992 6998 7002
32. A.J. van Zonneveld, S.A. Curriden, and D.J. Loskutoff Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter Proc. Natl. Acad. Sci. U.S.A. 85 15 1988 5525 5529
33. D.E. Vaughan, S.A. Lazos, and K. Tong Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis J Clin. Invest. 95 3 1995 995 1001